5USQ | ALK-5 kinase inhibitor complex | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Dougan, D.R., Lawson, J.D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.55 | ||||||||||||
ligand | 8LY | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors., Sabat M, Wang H, Scorah N, Lawson JD, Atienza J, Kamran R, Hixon MS, Dougan DR, Bioorg Med Chem Lett. 2017 May 1;27(9):1955-1961. doi:, 10.1016/j.bmcl.2017.03.026. Epub 2017 Mar 14. PMID:28359790 |
Data retrieval |
View 5USQ in 3D |
Visual 3D analysis of 5USQ |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5USQ |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |